Identification of molecular signatures specific for distinct cranial sensory ganglia in the developing chick by Patthey, Cedric et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Identification of molecular signatures specific for distinct cranial
sensory ganglia in the developing chick
Citation for published version:
Patthey, C, Clifford, H, Haerty, W, Ponting, CP, Shimeld, SM & Begbie, J 2016, 'Identification of molecular
signatures specific for distinct cranial sensory ganglia in the developing chick' Neural Development, vol. 11,
no. 1, pp. 3. DOI: 10.1186/s13064-016-0057-y
Digital Object Identifier (DOI):
10.1186/s13064-016-0057-y
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Neural Development
Publisher Rights Statement:
© Patthey et al. 2016
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
RESEARCH ARTICLE Open Access
Identification of molecular signatures
specific for distinct cranial sensory ganglia
in the developing chick
Cedric Patthey2,4†, Harry Clifford1,3†, Wilfried Haerty1,3*, Chris P. Ponting1,3, Sebastian M. Shimeld2 and Jo Begbie1*
Abstract
Background: The cranial sensory ganglia represent populations of neurons with distinct functions, or sensory
modalities. The production of individual ganglia from distinct neurogenic placodes with different
developmental pathways provides a powerful model to investigate the acquisition of specific sensory
modalities. To date there is a limited range of gene markers available to examine the molecular pathways
underlying this process.
Results: Transcriptional profiles were generated for populations of differentiated neurons purified from distinct
cranial sensory ganglia using microdissection in embryonic chicken followed by FAC-sorting and RNAseq. Whole
transcriptome analysis confirmed the division into somato- versus viscerosensory neurons, with additional
evidence for subdivision of the somatic class into general and special somatosensory neurons. Cross-comparison
of distinct ganglia transcriptomes identified a total of 134 markers, 113 of which are novel, which can be used to
distinguish trigeminal, vestibulo-acoustic and epibranchial neuronal populations. In situ hybridisation analysis
provided validation for 20/26 tested markers, and showed related expression in the target region of the hindbrain
in many cases.
Conclusions: One hundred thirty-four high-confidence markers have been identified for placode-derived
cranial sensory ganglia which can now be used to address the acquisition of specific cranial sensory
modalities.
Keywords: Cranial sensory ganglia, Viscerosensory neuron, Somatosensory neuron, Cell type markers, Chicken,
FACS, Expression profiling
Background
The sensory nervous system is fundamental to perception
of our body’s external and internal environments. It is
generally accepted that distinct types of sensation are me-
diated by neurons specialised in responding to specific
stimuli, raising questions relating to how these distinct
groups of neurons differ, both at the level of physiological
function, and at the level of the acquisition of specific
phenotypes during development [1]. To this end, recent
publications have outlined transcriptome analysis of
sensory neurons in the trunk, identifying specific subsets
of somatosensory neurons [2, 3]. However, these studies
provide molecular signatures specifically for trunk som-
atosensory neurons, and do not encompass the many
other sensory modalities conveyed by cranial sensory
neurons [4]. Our aim was to develop a resource which
would address the paucity of markers known to distin-
guish between neurons characteristic of distinct cranial
sensory ganglia.
The cranial sensory ganglia can be categorised as having
distinct sensory modalities according to the function of
their associated cranial nerve (Fig. 1A). The trigeminal
ganglion (which can be subdivided into ophthalmic and
maxillomandibular), associated with cranial nerve V, is
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considered most similar to the sensory dorsal root ganglia
(DRG) in the trunk, being involved in touch, pain and
temperature sensation. The vestibulo-acoustic ganglion,
associated with cranial nerve VIII, innervates the inner ear
structures involved in balance and hearing. The epibran-
chial ganglia, individually called geniculate, associated
with cranial nerve VII; petrosal, associated with cranial
nerve IX; and nodose, associated with cranial nerve X, are
involved in sensing chemicals such as tastants, digestive
catabolites, and blood gas levels, in addition to sensing
pressure changes in blood vessels. The cranial sensory
modalities thus correspond to somatosensation, which is
further subdivided into general somatosensory (trigeminal)
and special somatosensory (vestibulo-acoustic), and viscer-
osensation (geniculate, petrosal and nodose). Our study is
focused on the cranial sensory ganglia of chicken (Fig. 1A),
but their organisation and function are well conserved
across vertebrates [5].
The development of cranial sensory ganglia remains
less well studied than that of the DRG, possibly due to
their perceived complexity. Compared with the DRG,
which all develop exclusively from neural crest, each indi-
vidual cranial sensory ganglion develops from a distinct
neurogenic placode with some neural crest contribution to
the proximal cranial sensory ganglia: the proximal region
of the trigeminal ganglion, small numbers of neurons in
Fig. 1 Isolation of embryonic chick placode-derived cranial sensory neurons by dissection and FACS. A Schematic of cranial sensory ganglia in
embryonic day 12 (HH38) chick (adapted from [6]). The ganglia are labelled: trigeminal ganglion as two separate lobes (Top: ophthalmic; Tmm:
maxillomandibular); vestibulo-acoustic ganglion (VA); epibranchial series as three separate ganglia (G: geniculate; P: petrosal; N: nodose). Also labelled
are the neural crest-derived superior– jugular ganglionic complex (S/J); the inner ear (IE); and forebrain (FB); midbrain (MB) and hindbrain (HB) of the
CNS. Colours indicate the sensory modality of ganglion: blue: general somatosensory; magenta: special somatosensory; green: viscerosensory.
B Representative dissections of cranial sensory ganglia: Top, Tmm and VA at HH18, and P and N at HH23. C, D Representative FACS plots of
cells stained for live/dead stain and NFM. C Control cell population: limb bud cells devoid of neurons, containing 50 % dead cells. D Petrosal
ganglion cell population: 36 % of cells are NFM positive and dead cell marker negative
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the geniculate and vestibulo-acoustic ganglia, and the entir-
ety of the superior/jugular ganglia associated with cranial
nerves IX and X [6–8]. As each different neurogenic
placode utilises a distinct developmental path, they can
be used to understand the acquisition of different, specific
sensory modalities. Experiments addressing placode fate
switching through in vivo transplantation and in vitro path-
way manipulation, show that the trigeminal (somatosensory)
and nodose (viscerosensory) placode are fate-restricted
once neurogenesis begins [7, 9, 10]. In the mouse, ex-
pression of the transcription factor Phox2b underpins
the fate choice between these two sensory modalities
[11]. However, only a limited range of markers exist
that can be used to investigate this cell type decision,
and no markers are currently available to distinguish
between general and special somatosensory modalities.
To extend experimental analysis of cranial sensory gan-
glia development further, we require a broad range of
markers that distinguish between differentiated neurons
of different phenotypes.
Even neurons of the same sensory modality can differ de-
pending on whether they derive from neural crest or pla-
code. Analysis of the Scn10a gene promoter in the mouse
has shown that a specific fragment recapitulates endogenous
expression of the product Nav1.8 in neural crest-derived but
not placode-derived cranial sensory neurons [12]. Fur-
thermore, nociceptive C-fibre sensory neurons innerv-
ating the lung are phenotypically distinct depending on
whether they are neural crest- or placode-derived [13].
These observations reinforce the importance of produ-
cing markers that are specific for placode-derived cra-
nial sensory neurons.
The timing and localisation of distinct placode-derived
cranial sensory ganglion development have been carefully
documented in the chicken [6, 9, 10, 14–19]. Here we take
advantage of our knowledge of the development of the
chicken system, combined with genome-wide expression
profiling, to characterise ganglion-specific populations of
placode-derived sensory neurons at early stages of differ-
entiation. We present RNA-seq data generated from em-
bryonic neurons purified from five distinct cranial sensory
ganglia (namely trigeminal maxillomandibular; trigemi-
nal ophthalmic; vestibulo-acoustic; petrosal; and nodose
ganglia) separated by dissection and fluorescence-activated
cell sorting (FACS). Using this gene expression data, we
provide an objective and comprehensive classification of
distinct populations of cranial sensory neurons. Whole
transcriptome analysis confirms the dichotomy of somato-
sensory (somatic) versus viscerosensory (visceral) neurons,
but additionally provides molecular evidence for the sub-
division of the somatosensory neurons into general and
special somatosensory neurons as previously described
based on anatomy [11, 20]. Cross-comparison of distinct
ganglia transcriptomes identifies a total of 134 markers,
113 of them novel, which can be used to distinguish tri-
geminal, vestibulo-acoustic and epibranchial neuronal
populations. We confirm expression of 20 of these spe-
cific markers in the specific cranial sensory ganglia by in
situ hybridization. Taken together, our data provides mo-
lecular signatures for distinct cranial sensory neuronal
populations.
Results
Transcriptional profile analysis of cranial sensory ganglia
placode-derived neurons
In all vertebrates the cranial sensory ganglia are segregated
according to sensory function. In the chicken, the
stereotypical localisation of the ganglia (Fig. 1A) and
our detailed understanding of the timing of their develop-
ment [6, 14, 18, 19, 21] make it possible to dissect the gan-
glia separately in order to establish expression profiles of
distinct populations of developing sensory neurons. We
took advantage of this to harvest the trigeminal (maxillo-
mandibular and ophthalmic), vestibulo-acoustic, nodose
and petrosal ganglia from Hamburger-Hamilton stage 18
(HH18) [22] (both trigeminal and vestibulo-acoustic) or
HH23 (nodose and petrosal) chicken embryos (Fig. 1B).
Collection at these embryonic stages allowed us to com-
pensate for differences in the timing of ganglion develop-
ment, thus ensuring the neurons would be investigated at
a similar stage of differentiation [7, 14, 18, 19]. Further-
more, these specific timings meant that the population of
collected neurons exclusively contained placode-derived
neurons. This was of particular importance for the tri-
geminal ganglion where neural crest-derived neurons
contribute directly to the ganglion at later stages, rather
than forming separate ganglia [6, 8]. We confirmed that
we could avoid neural crest-derived neuron contamin-
ation of our trigeminal samples in a separate experiment,
specifically labelling neural crest cells with GFP and showing
that these did not contribute to the neuronal pool at
HH18 (Additional file 1: Figure S1). The trigeminal
ganglion was collected as two separate lobes (maxillo-
mandibular and ophthalmic) because these arise from
distinct placodes with individual characteristics [14, 18,
23], and further exist as two separate ganglia in more
basal vertebrates [5, 24].
In order to profile the transcriptomes of differentiated
neurons rather than non-neural cell types or neural pro-
genitors we isolated all cells positive for neurofilament
medium polypeptide (NFM) antibody staining. To this
aim we adapted transcription factor FACS (tfFACS) [25],
a method that allows sorting of cells with antibodies
raised towards intracellular epitopes. Briefly, freshly dis-
sected ganglia were quickly dissociated to single cells and
fixed, thereby freezing the cells in their transcriptional
state. The cells were gently permeabilised and subjected to
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NFM immunostaining, followed by FACS. Prior to fixation
the cells were treated with a live/dead stain, with the gate
for live/dead cells set using a control limb bud sample
containing 50 % of cells killed by heat-shock (Fig. 1C).
The extracted NFM positive (NFM+) neurons repre-
sented 13–41 % of the total cell population, while dead
cells (4–9 % of total) were excluded (Fig. 1D). A total of
20,000 to 290,000 NFM+ neurons per sample were col-
lected by FACS and 50-200 ng of high quality total
RNA extracted (Additional file 2). Following this, RNA-
sequencing returned a mean of ~77 million (~30–116
million) 100 bp reads for each of three replicates, of
which an average of 88 ± 6 % mapped to the genome
assembly. An average of 11,800 (10,897–12,190) genes
per sample were expressed at an appreciable level (>0.3
read per kilobase per million mapped reads (RPKM),
Additional file 3).
Principal Component Analysis (PCA) of gene expression
across all samples revealed two distinct, unambiguous
clusters indicative of two distinct categories of cranial sen-
sory ganglia captured by the first principal component
(Fig. 2A). None of the principal components significantly
correlated with RNA integrity measurements (RIN values),
RNA yield or sequencing depth (Additional file 2;
Additional file 4: Figure S2A, B, C). The clusters reflected
the known segregation of viscerosensory neurons (nodose
and petrosal) and somatosensory neurons (vestibulo-
acoustic and trigeminal) [11]. However, the two clusters
also reflected the different embryonic stages of dissection.
To test levels of neuronal maturation, we examined ex-
pression levels of six known markers of differentiated
neurons (ELAVL4 (HUD), ISL1, MYT1, NEUROD1,
RBFOX3 (NEUN) and TUBB3 (Tuj1)). Levels of expres-
sion were similar across the two sets of samples, sup-
porting the hypothesis that the clusters reflect
sensory phenotype rather than maturation differences
(Additional file 5: Figure S3).
The projections of the samples on PC1 and PC2 also show
separation of the somatosensory cluster into a trigeminal
cluster and a vestibulo-acoustic cluster (Fig. 2A): a conclu-
sion further strengthened by analysis of the other principal
components (Fig. 2B). This supports the segregation of these
ganglia into general (trigeminal) and special (vestibulo-
acoustic) somatosensory ganglia, terminology which has
been applied largely based on the anatomy of their central
projections with less known about the molecular basis [20].
Thus, our transcriptome-wide analysis supports a clear
separation of cranial sensory ganglia into viscerosensory
(nodose/petrosal) and somatosensory modalities (trigeminal/
vestibulo-acoustic) with further subdivision of the latter into
general (trigeminal) and special (vestibulo-acoustic) somato-
sensory modalities.
To identify ganglion-specific gene markers, differentially
expressed genes were determined using both DESeq and
EdgeR algorithms [26, 27], with the resultant intersect
taken to ensure a robust selection. All combinations of
ganglia were tested, and differentially expressed genes
from both sets of analysis are available as Additional file 6.
We were particularly interested in differential expression
that reflected the PCA separation of the ganglia into three
clusters. Accordingly our analysis identified higher expres-
sion of 1249 genes in nodose/petrosal; 447 in trigeminal
Fig. 2 Principal Component Analysis of transcriptome-wide data displaying ganglion-specific clustering. A A plot of the first two principal components
from analysis on all variance-stabilized gene expressions, coloured by ganglion. B Plot of the first and fourth principal components from analysis as in
(A). The grey ellipses represent 90 % confidence intervals for groupings
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and 133 in vestibulo-acoustic (Fig. 3A). The numbers of
up-regulated genes for other combinations of ganglia
were: nodose: 169; petrosal: 7; trigeminal maxilloman-
dibular: 60; trigeminal ophthalmic: 107; and trigeminal
maxillomandibular/trigeminal ophthalmic/vestibulo-acoustic:
708 (Additional file 7: Figure S4A, Additional file 6). No dif-
ferentially expressed genes were found in the remaining
combinations of ganglia. Gene ontology (GO) term analysis
showed that each cluster of ganglia was characterised
by enrichment of a distinct set of GO categories. The
Fig. 3 Genes differentially expressed in Nodose and Petrosal (N/P), Trigeminal ophthalmic and maxillomandibular (Top/Tmm) and Vestibulo-acoustic
(VA) ganglia. A Number of differentially expressed genes (q < 0.05) reported by DESeq and EdgeR. B Significant Gene Ontology (q < 0.05) enrichment
for differentially expressed genes reported by both DESeq and EdgeR. Redundant GO terms were removed using REVIGO. The Hinton plot displays the
FDR (Benjamini and Hochberg) corrected q-value
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nodose/petrosal grouping showed the broadest spread
of categories, with adhesion and membrane proteins
being particularly enriched (Fig. 3B). The trigeminal
grouping was the most overtly neuronal with neuro-
transmitter and ion transport activity terms enriched
(Fig. 3B). Satisfyingly, the significant GO category for
the vestibulo-acoustic ganglion, which is associated
with the ear, was ear development (Fig. 3B). GO terms
enrichments for other combinations of ganglia are
listed in Additional file 7: Figure S4B.
Identification of high-confidence markers for specific
cranial sensory ganglia
Genes identified as being differentially expressed using
both DESeq and EdgeR were subjected to stringent se-
lection criteria based on expression level, fold-change,
and statistical significance (see Material and Methods) to
generate an unbiased panel of genes that best represent
individual ganglia and combinations of ganglia (Fig. 4A;
Additional file 8). The hierarchical clustering of the re-
sultant 134 markers (Fig. 4A) reflected the division of the
cranial sensory ganglia demonstrated by PCA (Fig. 2). The
traditional division was represented by 20 markers of the
somatosensory ganglia (trigeminal/vestibulo-acoustic) and
72 markers of the viscerosensory ganglia (nodose/petrosal)
were found. In addition, we found 9 markers specific for
the general somatosensory (trigeminal) and 15 markers
for the special somatosensory ganglia (vestibulo-acoustic).
The validity of the marker sets was confirmed by con-
sidering genes whose expression has been shown previ-
ously to be restricted to specific cranial sensory ganglia.
Thus trigeminal ophthalmic expressed PAX3 [10, 28, 29];
trigeminal maxillomandibular/ophthalmic ganglia expressed
DRG11 [30–32]; and nodose/petrosal ganglia expressed
PHOX2B [11, 21, 33–35]. Our panel of markers in-
cluded 7 genes expressed in the nodose ganglion but
not in the petrosal ganglion. These included the HOX
genes HOXB4, −D4, −B5, and -B6 (Fig. 4A) reflecting
the well-known distribution of HOX gene expression
along the rostro-caudal axis. In line with this, the more
anteriorly expressed HOX genes, HOXB1 and –B2 were
included in the nodose/petrosal grouping (Fig. 4A).
Surprisingly, POU4F1/BRN3A, a well-known marker
of somatosensory neurons in mammals [11, 36], was not
among our list of selected markers. This prompted us to
verify the presence and identity of POU4 family genes in
the chicken genome. We found two genes that corres-
pond to the mammalian Pou4f1/Brn3a and Pou4f2/Brn3b,
and an orthologue of amphibian Pou4f1.2 which was not
found in mammals (Additional file 9: Figure S5A). Ana-
lysis of the number of reads mapping to the POU4F1 and
POU4F1.2 loci (see Material and Methods) showed that
the two genes collectively are expressed at higher levels
in the somatosensory than in the viscerosensory ganglia,
as shown previously by in situ hybridization [14, 37]
(Additional file 9: Figure S5B).
GO analysis of the panel of high-confidence marker
genes as a whole demonstrated significant enrichments
for categories associated with the extracellular com-
partment, which may be a reflection of signalling
processes, and with transcription factors (Fig. 4B;
Additional file 10). There were also significant enrich-
ments in terms associated with blood vessel develop-
ment, likely to reflect the known overlap between
mechanisms regulating blood vessel and nerve guid-
ance [38] (Fig. 4B).
Validation and expression pattern of selected markers
Rather than validate gene expression for each grouping
of ganglia, we chose to focus on the groupings that gave
us markers of distinct sensory modalities, selecting genes
representative of trigeminal for general somatosensory,
vestibulo-acoustic for special somatosensory, and nodose/
petrosal for viscerosensory. From candidates for these gan-
glia, genes with the highest expression levels and fold
change of differential expression were selected for in situ
hybridization analysis in wholemount and on sections of
chicken embryos at stage HH21 (Figs. 5, 6, 7 and 8). Prior-
ity was given to transcription factors because they are
most likely to regulate the acquisition of sensory
phenotype. We recognise that our validation was not
comprehensive and that it does not exclude the possi-
bility that other genes in the panel are equally good or
even better markers.
Trigeminal ganglion-specific markers
The localisation of the cranial sensory ganglia in the
HH21 chick can be clearly visualised by in situ hybrid-
isation with ISL1, a marker of specific neuronal subsets
including sensory neurons, which we include to allow
comparison with expression in all ganglia (Fig. 5A). The
trigeminal ganglion with two lobes, maxillomandibular
and ophthalmic, lies at the level of the anterior hind-
brain and in cross-section the ganglion can be seen adja-
cent to rhombomere (r)2 (Fig. 5A, A’). The transcription
factor-encoding gene DRG11 (also known as DRGX,
PRRXL1) was our positive control for the trigeminal
ganglion [30, 32, 39, 40] (Fig. 5B-B”’).
In the category of transcriptional regulators we analysed
expression of PRDM12 (PR homology domain-containing
member 12). PRDM12, which is essential for human pain
perception, and is required for sensory neuron develop-
ment in mouse and Xenopus [41–43], showed strong tri-
geminal expression, with little to no staining in the other
cranial sensory ganglia (Fig. 5C-C”’).
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As markers with a potential link to adult neuronal
function we analysed expression of GAD2 (GABA syn-
thetic enzyme GAD65) and CHRNA3 and CHRNB4
(nicotinic acetylcholine receptor subunits alpha3 and
beta4). GAD2 expression in the PNS has been described
in DRG (chick) and trigeminal ganglia (rat), and Gad2
knockout mice are sensitised to pain [44–46]. Neuronal
nicotinic receptors composed of α3β4 subunits that are
more restricted in expression than other subtypes, are
present and show specific functions in the trigeminal
ganglion of rat [47–49]. Our in situ hybridisation ana-
lysis showed GAD2, CHRNA3 and CHRNB4 staining in
the trigeminal ganglion (Fig. 5D-F”’), which, in section,
was weaker and in fewer neurons than DRG11 and
PRDM12 (Fig. 5B’-F’).
Many of the trigeminal markers were expressed else-
where in the embryo, but importantly, expression was
not seen in the other cranial sensory ganglia (Fig. 5;
Table 1). We focus here on hindbrain expression as it is
relevant when considering potential sensory circuits.
Many of the markers showed expression at the level of
r2, the entry point in the hindbrain for trigeminal axons,
yet the anatomical extent of staining varied. PRDM12 was
observed in a domain of strong staining in the ventral
hindbrain extending from r2 into the spinal cord, and a
domain of weaker staining restricted to dorsal r2 (Fig. 5C).
DRG11 was detected in a distinct domain in dorsal r2
extending caudally to the otic vesicle (Fig. 5B). GAD2
expression was seen to extend anteriorly into r1, but
with no distinct domain in r2 (Fig. 5D). Expression of
CHRNA3 and CHRNB4 was not observed in the hind-
brain (Fig. 5E, F).
Vestibulo-acoustic ganglion-specific markers
The vestibulo-acoustic ganglion can be seen clearly with
ISL1 expression, located anterior-medial to the otic vesicle
(Fig. 5A) In cross-section the vestibulo-acoustic ganglion
is localised between the anterior otic vesicle and r4/r5 of
the hindbrain (Fig. 5A”).
There was not a strong positive control gene for the
vestibulo-acoustic ganglion because a molecular
distinction between special and general somatosen-
sory has not been described previously. However, two
transcriptional regulators, ESRRG (estrogen-related
receptor gamma) and HMX3 (H6 family homeobox 3;
also known as NKX5.1), have demonstrated roles in
the development of inner ear structures and are
important for hearing in both mice and humans [50–
55]. Here our analysis showed expression of HMX3 in
the ventromedial vestibulo-acoustic ganglion and
ESRRG in the dorsolateral vestibulo-acoustic gan-
glion, as well as in nascent neuronal cells migrating
into the vestibulo-acoustic ganglion from the otic
vesicle (Fig. 6A-B”’).
In the category of transcriptional regulators, we
analysed expression of IRX2 (Iroquois homeobox gene
family member 2); POU6F2 (POU domain, class 6,
transcription factor 2; also known as RPF1) and,
RUNX1 (runt-related transcription factor 1; also known
as AML1, Cbfa2). Expression patterns of IRX2 and
POU6F2 have been described in the developing chick
and mouse but no role has been reported in the
vestibulo-acoustic ganglion [56–59]. In mouse RUNX1
has a role in the development of the vestibulo-
acoustic ganglion [60] but is also expressed in TrkA+
nociceptive sensory neurons of the head and trunk,
including a scattered population in the trigeminal
ganglion [60, 61]. In our analysis IRX2 expression was
seen in the whole vestibulo-acoustic ganglion as well
as the ventral otic vesicle corresponding to the loca-
tion of vestibulo-acoustic ganglion neuron production
(Fig. 6C”). POU6F2 and RUNX1 were expressed spe-
cifically in sub-divisions of the dorsolateral vestibulo-
acoustic ganglion (Fig. 6D”, E”).
As markers with a potential link to signalling we analysed
expression of the signalling molecule FGF9, and two ki-
nases: LRRK1 (leucine-rich repeat kinase 1) and PKDCCB
(protein kinase domain containing, cytoplasmic b;
ENSGALG00000011166: a paralogue of PKDCC also
known as VLK). FGF9 is important for development of
aspects of the inner ear including the cochlear sensory
cells (also known as hair cells), but weak expression
has also been reported in the mouse cochlear/acoustic
ganglion (part of the vestibulo-acoustic ganglion com-
plex) [62, 63]. Neither LRRK1 nor PKDCCB has previ-
ously been linked to the vestibulo-acoustic complex
[64–67]. Our analysis showed expression of FGF9 in
the whole vestibulo-acoustic ganglion and LRRK and
PKDCCB in the dorsolateral vestibulo-acoustic gan-
glion (Fig. 6F-F” and Fig. 7A-B”).
As a marker linked to adult neuronal function we ana-
lysed expression of SCN3A (voltage gated sodium
(See figure on previous page.)
Fig. 4 134 high confidence ganglion-specific markers. A Variance stabilized gene expression of all markers in ganglia or groups of ganglia. Numbers of
ganglion-specific markers are indicated on the left. Genes of interest (black text) including those selected for validation by in-situ hybridization (blue
text) are shown on the right. The dendogram displays the hierarchical clustering of gene expression into ganglia and groups of ganglia. The magenta
and green values on each node represent the Approximately Unbiased P-value and the Bootstrap Probability value respectively. B Significant Gene
Ontology enrichment (q < 0.05) for all markers. Redundant GO terms were removed using REVIGO. The Hinton plot displays the FDR (Benjamini and
Hochberg) corrected q-value
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channel type 3, alpha subunit) which in humans lies
within a chromosomal locus associated with hearing
loss. Expression of SCN3A has not been characterised in
the vestibulo-acoustic ganglion in humans or mice [68].
Our analysis showed expression in the dorsolateral
vestibulo-acoustic ganglion (Fig. 7C, C”).
In addition to the vestibulo-acoustic ganglion, all of the
analysed genes showed expression elsewhere in the
Fig. 5 Expression patterns of trigeminal ganglion-specific markers. A) Wholemount in situ hybridization of ISL1at HH21 to provide anatomical localisation
of all cranial sensory ganglia. A’-A”’) Transverse sections stained with ISL1at HH21 to provide comparative sections for other markers at the level of Tmm
ganglion (A’); VA ganglion (A”); and P ganglion (A”’). B-F) Wholemount in situ hybridization of trigeminal ganglion specific markers at HH21. B’-F”’)
Transverse sections at the level of the Tmm ganglion (B’-F’), VA ganglion (B”-F”) and P ganglion (B”’-F”’) stained with the named marker at
HH21, showing Tmm-specific expression. B-B”’) DRG11; C-C”’) PRDM12; D-D”’) GAD2; E-E”’) CHRNA3; F-F”’) CHRNB4. Levels of staining in the trigeminal
ganglion vary, but are stronger when compared with other ganglia. Staining can be seen in the NT although specific localisation and level varies. The
dark staining in the eye and OV in D-F was not observed on sections and likely represents background. Abbreviations: G: geniculate ganglion;
N: nodose ganglion; NT: neural tube; OV: otic vesicle; P: petrosal ganglion; r: rhombomere; Top: trigeminal ophthalmic lobe; Tmm: trigeminal
maxillomandibular lobe; VA: vestibulo-acoustic ganglion. Scalebars: A-F: 500 μm; A’-F”’: 150 μm
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embryo (Figs. 6 and 7; Table 1). SCN3A and LRRK1
showed weak staining in other cranial sensory ganglia, but
were significantly stronger in the vestibulo-acoustic gan-
glion. Within the hindbrain the extent of expression var-
ied. Analysis of sections at r4, the site of vestibulo-
acoustic ganglion axon entry, showed ESRRG, POU6F2,
PKDCCB, and SCN3A staining in a similar pattern from
dorsal to ventral (Fig. 6A”, D” and Fig. 7B”, C”). HMX3
and RUNX1 were expressed in discrete domains in dorsal
r4 and in ventral regions extending beyond r4 (Fig. 6B”,
Fig. 6 Expression patterns of vestibulo-acoustic ganglion-specific markers. A-F) Wholemount in situ hybridization of vestibulo-acoustic ganglion
specific markers at HH21. A’-F”’) Transverse sections at the level of the Tmm ganglion (A’-F’), VA ganglion (A”-F”) and P ganglion (A”’-F”’) stained
with the named marker at HH21, showing VA-specific expression. A-A”’) ESRRG; B-B”’) HMX3; C-C”’) IRX2; D-D”’) POU6F2; E-E”’) RUNX1; F-F”’) FGF9.
Levels of staining in the vestibulo-acoustic ganglion vary, but are stronger when compared with other ganglia. In ESRRG staining is also seen in
nascent neurons migrating from the OV (arrowhead). Staining can be seen in the NT although specific localisation and level varies. The dark
staining in the eye and OV in B and E was not observed on sections and likely represents background. Abbreviations: NT: neural tube; OV: otic
vesicle; P: petrosal ganglion; Tmm: trigeminal maxillomandibular lobe; VA: vestibulo-acoustic ganglion; arrowhead: nascent neurons migrating
from OV. Scalebars: A-I: 500 μm; A’-I”’: 150 μm
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E”). LRRK1 signal was found in a restricted ventral domain
(Fig. 7A”) while IRX2 and FGF9 staining was broadly dis-
tributed throughout the r4 neuroepithelium (Fig. 6C”, F”).
Epibranchial ganglia-specific markers
The petrosal and nodose ganglia represent the epibran-
chial series of cranial sensory ganglia which can be identi-
fied clearly in the HH21 ISL1 stained embryo (Fig. 5A). In
cross-section, we focused on the petrosal ganglion located
near the pharyngeal endoderm, at a distance from r6/7 of
the hindbrain (Fig. 5A”’). The transcription factor
PHOX2B represented the positive control for the epibran-
chial ganglia [21, 33–35] (Fig. 8A, A”’).
We analysed expression of two transcription
factors-encoding genes: PROX2 (prospero-related
homeobox gene family, member 2) and SHOX (short
stature homeobox transcription factor). PROX2 ex-
pression has been described in cranial sensory ganglia
in zebrafish and more specifically in the epibranchial
ganglia in mouse [69, 70]. SHOX, important for
growth in humans and zebrafish, is absent in mouse
where instead the related gene Shox2 is required for
long bone growth [71–73]. Roles for mouse Shox2 in
neuronal development have been shown, and expres-
sion reported in cranial sensory ganglia [74, 75]. Our
analysis showed specific expression of PROX2 and
SHOX in the epibranchial ganglia (Fig. 8B-C”’). In
cross section the staining for these markers was scat-
tered throughout the ganglion, suggesting that these
genes’ expression may differentiate subsets of neurons
(Fig. 8B”’, C”’).
Other genes which we identified as good markers of
the epibranchial ganglia have not been well studied at ei-
ther the expression or functional level. CTXN1 (Cortexin 1),
encodes a single trans-membrane domain protein
identified in mouse and rat cortex [76]. PDZRN4 (PDZ
and Ring domain-containing family member 4; also
known as LNX4 (ligand of Numb protein-X)) was
identified in silico and remains largely uncharacterised
[77–79]. SULT4A1 is a member of the sulfotransferase
family, cytosolic enzymes proposed to play roles in the
modulation of certain neurotransmitters, and is expressed
in the human and rat brain [80, 81]. Our analysis showed
expression in the epibranchial ganglia (Fig. 8D-F). As
for PROX2 and SHOX, the proportion of cells stained
in the petrosal ganglion varied with each marker
(Fig. 8E”’, F”’).
All of these genes showed expression elsewhere in the
embryo, with the most restricted being PROX2 (Fig. 8;
Table 1). SULT4A1 showed weak staining in the other
Fig. 7 Expression patterns of vestibulo-acoustic ganglion-specific markers. A-C) Wholemount in situ hybridization of vestibulo-acoustic ganglion
specific markers at HH21. A’-C”’) Transverse sections at the level of the Tmm ganglion (A’-C’), VA ganglion (A”-C”) and P ganglion (A”’-C”’) stained
with the named marker at HH21, showing VA-specific expression. A-A”’) LRRK1; B-B”’) PKDCCB; C-C”’) SCN3A. Levels of staining in the vestibulo-
acoustic ganglion vary, but are stronger when compared with other ganglia. In LRRK1, PKDCCB and SCN3A staining is also seen in nascent
neurons migrating from the OV (arrowhead). Staining can be seen in the NT although specific localisation and level varies. The dark staining in
the eye and OV in A-C was not observed on sections and likely represents background. Abbreviations: NT: neural tube; OV: otic vesicle; P: petrosal
ganglion; Tmm: trigeminal maxillomandibular lobe; VA: vestibulo-acoustic ganglion; arrowhead: nascent neurons migrating from OV. Scalebars:
A-I: 500 μm; A’-I”’: 150 μm
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cranial sensory ganglia, but was significantly stronger in
the epibranchial ganglia (Fig. 8F’-F”’). In the hindbrain our
analysis focused on r6, the site of entry for petrosal axons.
SHOX expression resembled that of PHOX2B, with
discrete staining in dorsal and ventral domains, and a
small number of stained cells extending between these
two domains (Fig. 8A”’, C”’). PDZRN4 also showed distinct
dorsal and ventral domains of staining (Fig. 8E”’), while
CTXN1 or SULT4A1 expression was restricted to a very
small ventral domain (Fig. 8D”’, F”’).
The expression patterns of 20 out of 26 tested
markers validated the differential expression in cranial
Fig. 8 Expression patterns of epibranchial ganglia-specific markers. A-F) Wholemount in situ hybridization of epibranchial ganglia-specific markers
at HH21. A’-F”’) Transverse sections at the level of the Tmm ganglion (A’-F’), VA ganglion (A”-F”) and P ganglion (A”’-F”’) stained with the named
marker at HH21, showing P-specific expression. A-A”’) PHOX2B; B-B”’) PROX2; C-C”’) SHOX; D-D”’) CTXN1; E-E”’) PDZRN4; F-F”’) SULT4A1. Levels of
staining in the epibranchial ganglia vary, but are stronger when compared with other ganglia. Staining can be seen in the NT although specific
localisation and level varies. The dark staining in the eye and OV in A, B, D and F was not observed on sections and likely represents background.
Abbreviations: G: geniculate ganglion; N: nodose ganglion; NT: neural tube; OV: otic vesicle; P: petrosal ganglion; Tmm: trigeminal maxillomandibular
lobe; VA: vestibulo-acoustic ganglion. Scalebars: A-F: 500 μm; A’-F”’: 150 μm
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sensory ganglia revealed by RNA-seq (Table 1). For
each group there were exceptions where the in situ
hybridisation analysis did not match expectations.
These fell into two categories: i) genes which
showed no, or very low, in situ signal where expected
(LHX4, OTX2, TOX2) (Additional file 11: Figure S6A-
C); and ii) genes which showed high in situ signal
in surrounding tissue but not in the ganglion
(MECOM, PRRX1 and PRRX2) (Additional file 11:
Figure S6D-F).
Discussion and conclusions
It has long been recognised that the cranial sensory gan-
glia represent distinct sensory functions. Nevertheless,
analysis of mechanisms underlying the development of
specific cranial sensory modalities has been limited by
the paucity of markers for the different cell populations.
To overcome this restriction we set out to identify mo-
lecular signatures for the distinct cranial sensory ganglia
at early stages of neuronal differentiation. Here we report
the generation of ganglion-specific expression profiles
using transcriptome-wide analysis of placode-derived neu-
rons from isolated cranial sensory ganglia in the develop-
ing chicken embryo. Differential expression analysis of the
resultant data set showed differences in the profiles that
correlate with distinct functions and sensory modalities.
Principal component analysis revealed three separate
clusters, capturing the segregation of the cranial sensory
ganglia into viscerosensory epibranchial ganglia (nodose/
petrosal); general somatosensory trigeminal ganglia;
and special somatosensory ganglia (vestibulo-acoustic
ganglion). Our study was not designed to assess the
Table 1 Summary of selected marker genes expression in the head as assessed by in situ hybridization
Cranial sensory ganglia Other PNS sites
Top Tmm VA G P N
Trigeminal DRG11 +++ +++ - - - -
PRDM12 +++ +++ - + (distal) + (distal) + (distal) Olfactory epithelium, ciliary
ganglion, otic macular patches
GAD2 ++ ++ - - - -
CHRNB4 + + - - - -
CHRNA3 + + - - - -
TOX2 (+) (+) - - - -
OTX2 (+) (+) - - - - Ventral otic vesicle
Vestibulo-acoustic ESSRG - - +++ - - -
PKDCCB - - +++ - - - Otic macular patches
LRRK1 + (distal) + (distal) +++ - - -
POU6F2 + (distal) + (distal) +++ - - -
RUNX1 - - ++ - - -
IRX2 - - ++ - - - Otic vesicle
FGF9 - - ++ - - -
SCN3A + + +++ + + + Terminal nerve ganglion
HMX3 - - + - - - Dorsal otic vesicle
Epibranchial PHOX2B - - - +++ +++ +++ Ciliary ganglion
PROX2 - - - ++ ++ ++ Lens
CTXN1 - - - +++ +++ +++
SULT4A1 + (distal) + (distal) + +++ +++ +++ Ciliary ganglion, terminal nerve
ganglion
PDZRN4 - - - ++ ++ ++
SHOX2 - - + +++ +++ +++
LHX4 - - - - (+) (+)
MECOM - - - - - -
PRRX1 - - - - - - Medial otic vesicle
PRRX2 - - - - - -
Expression levels at stage HH21 are given for the cranial sensory ganglia (Top trigeminal ophthalmic, Tmm trigeminal maxillomandibular, VA vestibulo-acoustic,
G geniculate, P petrosal, N nodose), as well as other sites in the PNS
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distinction between cranial and trunk sensory neurons.
Using stringent selection criteria, we report a total of
134 marker genes specific for particular cranial ganglia
or groups of ganglia, and show validation of 20/26 by in
situ hybridization. Of our panel of marker genes, around
20 were known to have either described expression in sen-
sory neurons, or a link to dysfunction of the relevant sen-
sory system. However, 113 were entirely novel, with no
previously described sensory neuron-specific expression.
Importantly, we identify and validate several marker
genes that differentiate between the trigeminal and
vestibulo-acoustic neurons, providing the first molecu-
lar signature for the distinction between embryonic
“general” and “special” somatosensory neurons. Our
validation was restricted to a single stage (HH 21) in a
single species (chick), and the observed differential ex-
pression might be a consequence of temporal differ-
ences in the onset of expression. However, we expect
the markers to be generally valid across stages and ver-
tebrate species.
The range of genes encompassed by our panel in-
cluded transcriptional regulators, components of signal-
ling pathways and ion channels (Fig. 4; Additional file 8).
As a resource this panel of ganglion-specific markers
will enable us to analyse experiments in greater depth
to further our understanding of the acquisition of the
respective sensory modality. They will be important in
unambiguously determining the fate adopted by cells
when extracellular signals or transcriptional regulators
are modulated in experimental settings, for example in
protocols aimed to derive specific sensory neurons
from human pluripotent stem cells [82].
At an individual gene level, it will be interesting to
investigate their roles in producing or maintaining
sensory phenotype through knockdown and ectopic
expression in the future. It is possible that trans-
cription factors play a role as regulators of cell type
identity, acting in concert with known genes such as
BRN3A and PHOX2B [11, 83]. We also note that
several ligands and receptors, all of which have a
demonstrated role in cell migration and/or axon guid-
ance, were expressed differentially between the classes
of cranial sensory ganglia, such as the netrin family
gene NTNG1 and the Robo ligand SLIT3 in nodose/
petrosal viscerosensory neurons, or the chemokine
receptor CXCR4 in trigeminal (ophthalmic/maxillo-
mandibular) and vestibulo-acoustic somatosensory
neurons [84–86].
The ganglion-specific expression was readily appar-
ent for the majority of the markers tested. Within each
group we found cases which further showed expres-
sion in the target region for ganglionic projections in
the hindbrain. For example, we showed expression of
ESSRG and POU6F2 in the dorsal-most domain
specifically at r4-5 level, where vestibulo-acoustic gan-
glion afferents enter the brainstem. Such co-ordinate
gene expression in both sensory neurons and their tar-
get central neurons has been shown to be important
for correct connectivity in both head and trunk [11,
39, 87]. Thus, our data supports the idea of a “sensory
type code” aligning sensory neurons with central neu-
rons of the same circuit. This might have functional
consequences in the establishment of specific viscero-
and somatosensory circuits and/or represent ancient
evolutionary relationships.
Genome-wide analysis of gene expression consid-
ered pooled populations of neurons from each cranial
ganglion, revealing groups of viscerosensory, general
somatosensory and special somatosensory neurons.
Our analysis of expression patterns by in situ hybrid-
isation demonstrated that, as established in the trunk
somatosensory population [2, 3], there are further subsets
within these populations. It is recognised that the
vestibulo-acoustic ganglion represents a complex of two
smaller ganglia individually containing neurons involved
in balance and hearing [88]. Interestingly, comparison in
transverse section of all vestibulo-acoustic ganglion
markers showed that they occupied different regions
(Figs. 6 and 7). This may be due to expression in specific
subgroups of neurons such as vestibular neurons versus
auditory neurons, known to occupy separate regions
within the vestibulo-acoustic ganglion complex in mouse
[88]. Further analysis would have to be performed to de-
termine the allocation to specific functions. Many of the
trigeminal and epibranchial ganglia markers exhibited
scattered expression rather than homogeneous staining
throughout the ganglion as observed for ISL1 or PHOX2B
(Figs. 5, 6, 7 and 8). Thus, our markers highlight further
complexity in the specific subtypes of sensory neuron.
The broad distinction between viscero- and somatosen-
sory neurons has been more widely studied. The viscero-
sensory system is important in controlling the body’s
internal milieu including many autonomic reflexes such as
baroreflex regulation of the cardiovascular system [89],
hypoxia regulation of the ventilatory response [90] and
nutrient-induced inhibition of food-intake [91]. The gen-
eral somatosensory system is involved in response to exter-
nal stimuli: in rodents the importance of touch from the
whiskers can be seen in the somatotopy of the whisker bar-
rels in the cerebral cortex [92]; in humans trigeminal in-
volvement in pain sensation can become problematic
leading to migraine and trigeminal neuralgia [93]. To date
the molecular fingerprint used to recognise developing
viscerosensory neurons is Phox2a + Phox2b + Ret +
Brn3a– Drg11– Runx1–, while that for somatosensory
neurons is Phox2a– Phox2b– Ret– Brn3a +Drg11+
Runx1+. Using this limited marker set, a seminal study
found that Phox2b acts as a regulatory switch between
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the two phenotypes: in Phox2b mutant mice, the neu-
rons of the epibranchial ganglia up regulate Brn3a
leading to expression of Drg11 and Runx1, and hence
to the conclusion that they become somatosensory [11].
It would be interesting to re-examine this situation
more closely using our data set to determine how
complete this transition is, and whether the resulting
somatosensory cells are more similar to trigeminal or
vestibulo-acoustic neurons.
Analysis in Brn3a mutant mice showed changes in the
subtype of somatosensory neuron specified within the
trigeminal ganglion, but did not examine whether the
neurons switched to a viscerosensory phenotype [83].
The studies did however, show a de-repression of genes
interpreted as non-neuronal [94]. Interestingly using
our panel of markers for specific cranial sensory neur-
onal populations, we can now identify some of these
genes as markers of the viscerosensory ganglia (e.g.,
ANGPTL1; PROX2) or special somatosensory ganglia
(e.g., IRX2) [94].
A complementary approach to address the generation
of different cranial sensory neuron phenotypes has
been to focus on the embryonic origins of the cranial
sensory ganglia. There are distinct neurogenic pla-
codes for each cranial sensory ganglion, each of which
has an individual developmental profile [95, 96].
Many studies have built up our understanding of pat-
terning the specific neurogenic placodes within the
cranial ectoderm across species [97]. However, while
this describes the mechanisms underlying the gener-
ation of the neurogenic placodes, it does not address
how or why progenitors located in different placodes
acquire distinct neuronal phenotypes. It will be inter-
esting to interfere with aspects of neurogenic placode
development, for example by transplantation or treat-
ment with specific signalling molecules [7, 9, 10], and
to use our panel of molecular markers to determine
the effects on viscero- versus somatosensory neuronal
differentiation.
The organisation and function of the cranial sensory
ganglia is highly conserved across vertebrates. The origin
of the cranial sensory ganglia from neurogenic placodes
also attracts considerable interest from an evolutionary
perspective. Historically neurogenic placodes have, together
with neural crest cells, been suggested to be vertebrate in-
novations, enabling the transition to a predatory lifestyle
[98], and their presence in other organisms has been
examined [96, 97, 99, 100]. As with development, many
of the studies to date focus on the evolution of neuro-
genic placodes rather than their derived sensory neurons.
Provided homologous genes can be found in other organ-
isms, our molecular profiles will be invaluable in consider-
ing the evolutionary origin of the distinct sensory neuronal
phenotypes [96].
Methods
Embryonic dissection
Fertilized chicken eggs (Winter Egg Farm, UK) were in-
cubated in a humidified chamber at 38 °C to the correct
Hamburger and Hamilton (HH) stage of development
[22]. To compensate for differences in the timing of mi-
gration and neuronal differentiation/maturation in the dif-
ferent ganglia relative to the age of the embryo, trigeminal
maxillomandibular and ophthalmic and vestibulo-acoustic
ganglia were dissected at HH18, while the nodose and pe-
trosal were dissected at HH23 [7, 21]. These stages also
take into account that neural crest-derived neurons differ-
entiate at later stages in the respective ganglia [6, 8].
The cranial nerve ganglia were dissected in L15 medium
(Gibco) using electrolytically sharpened 0.125 mm tung-
sten wire, nerve processes and mesenchyme were removed
and pooled ganglia kept on ice in L15 for 0–3 h until dis-
sociation. For each ganglion type, the left and right ganglia
of 40–60 embryos were pooled. All three replicates of the
different ganglia were collected independently from new
individuals.
Electroporations and immunostaining on sections
Eggs were windowed at HH12 and pCAβ-EGFPm5
vector electroporated into the neural crest on one side
of the embryo (n = 4) using an Electro Square Porator
ECM 830 (BTX.Inc) by applying 5 pulses (6 V, 25 ms)
at 1 s intervals. Eggs were sealed and incubated until
HH18. The embryos were fixed in 4 % paraformalde-
hyde in phosphate buffered saline (PBS) for 2 h on ice,
kept in 30 % sucrose in PBS for 3 h at 4 °C and embed-
ded in OCT compound (Andwin Scientific) for cryo-
sectioning. 10 μm sections were stained with anti-
NFM (clone RMO270, Invitrogen, 1:5000) primary and
Alexa596 anti-mouse (Life Technologies) secondary
antibodies.
Antibody staining and FACS
Cells were dissociated in trypsin-EDTA (Gibco) for 5 min
at 37 °C followed by inactivation with defined trypsin in-
hibitors (Gibco) and trituration with a 200 μl pipette tip.
At all subsequent steps cells were pelleted in protein
LoBind tubes (Eppendorf) at 500xg for 1 min at 4 °C and
otherwise kept on ice. Live cells were treated with Near-IR
fixable live/dead stain (Invitrogen) in PBS for 5 min ac-
cording to the manufacturer’s instructions. Cells were
fixed for 10–15 min in 200 μl 4 % paraformaldehyde made
in MOPS buffered saline (MBS) containing 0.1 M MOPS
pH7.4, 1 mM EGTA, 2 mM MgSO4 and 125 mM NaCl.
Cells were permeabilized in permeabilization buffer (PB)
containing 2 % BSA, 0.1 % saponin, 5 mM DTT and
100U/ml RNAse inhibitor (Roche) in MBS. Remnants of
paraformaldehyde were inactivated by addition of glycine
pH 8.0 to a final concentration of 100 mM. Cells were
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subsequently incubated 10–15 min on ice in anti-NFM in
PB (clone RMO270, Invitrogen, 1:5000). The primary anti-
body was replaced by anti-mouse Alexa488 secondary
antibody in PB (Invitrogen, 1:1000) and cells were incu-
bated 10 min on ice. Cells were washed briefly in MOPS-
RNasin-DTT-BSA (MRDB) buffer containing 2 % BSA,
5 mM DTT and 100U/ml RNAse inhibitor (Roche) in
MBS, re-suspended in 70 μl RNA-later (Ambion) and
kept overnight at 4 °C. Cells were diluted by addition of
250 ml MRDB, pelleted and resuspended in 400 μl
MRDB. Cells were sorted on a MoFlo Astrios sorter.
Gates were set using a control sample from HH23 limb
bud treated in the same way as the cranial nerve gan-
glia samples. The control limb sample included 50 % of
cells killed by a 5 min 60 °C heat shock to set the gate
for live/dead staining. Cells were sorted into 1.5 ml pro-
tein low-bind tubes containing 70 μl MRDB chilled to
4 °C during sorting. The cells were pelleted in MRDB
and lyzed in RLT lysis buffer (Qiagen) containing 1 %
2-mercaptoethanol.
RNA extraction and sequencing
Total RNA was extracted using an RNeasy micro kit
(Qiagen) using the modified protocol for fixed cells as
per the manufacturer’s instructions. Genomic DNA
was eliminated by an on-column DNase-I treatment.
RNA integrity was assessed using the Experion system
(Biorad) and RNA quantity was measured using Qubit
high-sensitivity kit. Libraries were prepared using Illu-
mina mRNA-seq kit incorporating poly-(A) selection
without further amplification and 100 bp paired-end
reads were sequenced on an Illumina Hi-seq 2000
platform at the High-Throughput Genomics unit at
the Wellcome Trust Centre for Human Genomics,
Oxford, UK. Three biological replicates of each sample
were generated and assigned to different lanes, with 5
samples multiplexed on each lane. The raw reads have
been uploaded to the Short Read Archive (SRA, Ac-
cession number SRP068496).
Read mapping, quantification, and differential expression
Read quality was assessed using FASTQC. rRNA reads
were identified by mapping the raw reads to chicken
rRNA sequences (accession numbers: Galga 18S rRNA
HQ873432.1; Galga 28S rRNA EF552813.1; Galga 5S
rRNA NR046276.1; Galga 5.8S rRNA DQ018753.1)
and removed from the dataset. After removal of the
identified rRNA, unprocessed reads were aligned to
the galGal4 chicken genome assembly (Ensembl Re-
lease 71) using the splice-aware sequence aligner
Gsnap [101]. MISO [102] was used to determine an
average expected insert size of 116 ± 72 bp. These
values were then applied in a subsequent Gsnap iter-
ation for more accurate paired alignment. HTseq
count [103] was used on the most conservative setting
(intersection strict) to count reads mapped to gene
models, which were determined using the Ensembl
galGal4 reference genome, version 71. Normalization
was performed with DEseq [26] and EdgeR [104]. Dif-
ferential expression analysis was performed with both
DESeq and EdgeR, with differentially expressed genes de-
fined as only those returned by both of these methods of
analysis, with an FDR (q-value) of 0.05 or below.
Selection of markers
Prior to estimating the gene expression of ganglia-specific
markers, duplicated read pairs were identified using
Picard Tools’ Mark Duplicates function. Markers were
selected from this pool of differentially expressed genes
through the following criteria: 1) expression levels 1.5-
fold higher in all samples of the high-group than all
samples in the low-group; 2) minimum RPKM of 10 in
the high-group; and 3) q-value < 0.05 in both DESeq
and EdgeR analyses.
Functional annotation
Gene Ontology (GO) term enrichment analyses were
implemented through DAVID [105]. This analysis was
applied to the differentially expressed genes identified
for each ganglion and groups of ganglia in turn,
against a background of all expressed genes, where
expressed genes are defined as those where at least
one transcript of that gene had a minimum of 80 %
coverage. The threshold for significance was set as
below 0.05 for the Benjamini and Hochberg q-value
returned by DAVID.
Analysis of POU4F1
Since no gene model for POU4F1 was included in the
genome version used, reads mapped as described to the
GENBANK model XM_003640558.2 were counted using
HTseq with the same settings as for the Ensembl gene
models as described above.
Pou4 family protein sequences were collected from
GENBANK using a BLASTp approach and aligned using
MAFFT with default settings. The alignment was trimmed
manually in BioEdit [106]. A maximum likelihood tree
was built using MEGA version 5.2 [107]. The Jones-
Taylor-Thornton (JTT) amino acid substitution matrix
was used and 150 bootstrap iterations were used to ob-
tain support values at each node.
Cloning
Chick cDNA from HH18-24 heads was used for PCR
cloning of the markers tested. See primers below.
Products were cloned into pGEMT (Promega) or
pCRII (Invitrogen).
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Other constructs were obtained: DRG11 from Prof. J Cohen
(KCL, London), PHOX2B from Prof, JF Brunet (ENS, Paris).
In situ hybridisation
Wholemount in situ hybridisation was carried out as de-
scribed previously [8] with incubation at 65 °C. An RNAse
incubation step (15mins, 37 °C) was included post-
hybridisation. For in situ hybridization on section, embryos
were fixed in 4 % paraformaldehyde in MOPS buffer (MB)
containing 100 mM MOPS (pH 7.5), 1 mM EGTA and
2 mM MgSO4 for 12 h at 4 °C. Embryos were then treated
in 15 % sucrose in MB for 10 h and 30 % sucrose in MB
for 2 h, and embedded in OCT compound (Andwin
Scientific). 10 μm cryosections were collected and proc-
essed for in situ hybridization as previously described [108].
Additional files
Additional file 1: Figure S1. Analysis of NFM expression in neural crest-
derived cells of the trigeminal ganglion at stage HH18. A-F) Immunostaining
for NFM (magenta) on sections at the level of the trigeminal ophthalmic
(Top, A-C) or trigeminal maxillomandibular (Tmm, D-F) ganglion in
HH18 chicken embryos in which a GFP-expressing construct was
electroporated in the dorsal midbrain-hindbrain region at stage HH12.
GFP expression (green) indicates origin in the cranial neural crest. GFP-
positive neural crest-derived cells are NFM-negative (C and F). Scale bar:
50 μm. (PDF 6525 kb)
Additional file 2: Information for each of the 15 samples. Number of
embryos dissected, number of ganglia included, proportion and number
of cells sorted, quantity and integrity (RIN number) of RNA extracted,
sequencing depth and proportion of reads mapped and number of
genes expressed are indicated for each replicate. Genes are counted as
expressed if RPKM > 0.3. (XLSX 10 kb)
Additional file 3: Normalized expression levels. Number of mapped
reads per kilobase of exon per million reads (RPKM) is given for each
gene and for each of the 15 replicates. (XLSX 3748 kb)
Additional file 4: Figure S2. A) Pearson coefficients of correlation
between principal components 1–15 and RIN values. B) Pearson coefficients
of correlation between principal components 1–15 and RNA quality. C)
Pearson coefficients of correlation between principal components 1–15 and
read counts. (ZIP 179 kb)
Additional file 5: Figure S3. Expression levels of neuronal differentiation
markers. Expression levels as measured by RNA-seq (RPKM) for the indicated
gene is shown for the 5 ganglia (Top: trigeminal ophthalmic; Tmm:
trigeminal maxillomandibular; VA: vestibulo-acoustic; Pet: petrosal;
Nod: nodose). Error bar: standard error of mean (s.e.m). (PDF 1432 kb)
Additional file 6: Differential expression analysis results for all
pairwise comparisons between ganglia using both DESeq (i) and
Gene name Forward primer Reverse primer
CHRNA3 ATGTGACCTGGATACCCCCA CTTCATCACTGGTCGGCCTT
CHRNB4 AGTGTGAACGAACGAGAGCA ACAGGTAGGCTGGGAGTCTT
CTXN1 GAGCTCTCGGTCTGCACAG CATCCCTGCCCTCTACACCA
ESRRG TCTGACGGACAGCATCAACC AGGGTTCAGGTACGGGCTAT
FGF9 TTTGCTCAGTGACCACCTGG TCAGGGTCCACTGGTCTAGG
GAD2 TGGTGTTGAAAGGGCCAACT TCCTGATGAGTTGCTGCTGG
HMX3 CAAGAACCTGCTCAACGGAG CGCTTCATGTCGAAGGTGGA
IRX2 CAGGGTTACCTCTACCAGCC TTGCAAGCTGATCCCTTCGT
LHX4 TACCTGATGGAGGACGGGAG CTCGGAGAGGATCTGGTCGT
LRRK1 CCTTGCCTACCTGCACAAGA CTGCTACGAGTCCATCCGAC
MECOM AAAGCCATGGTAACCAGCCA ATTGGATGGCGCTGGATTCT
OTX2 CGGGCATGGATTTGTTGCAT GGTGGTGCATAGGGGTCAAA
PDZRN4 TGGCTCTGGCCAAACTAAGG CTCCACCTCATTGGCTGTGT
PKDCCB ACTGCACACTTGACTTCCCC AGCGTGGGAACAGCTAAACA
POU6F2 CCGTCATCGGCAACCAGATA CCATAGGAACTGCTGTCGCA
PRDM12 TGATCACGTCCGACATCCTG TGAGTTCCCGTACCAGACCA
PROX2 TCCTCGACGTGCAGTTCAGC CGCAGCTTTGAACACTTCGG
PRRX1 TTTCCGTGAGTCACCTGCTG ACTGTGGGCACTTGATTCCT
PRRX2 CCCTCAGAGCCGGAAAAACT CTGGTTCTGATGCAGGCTGA
RUNX1 AACCCAGAAACACGAGGCAA CCCTTCTGCCTCAACCACAT
SCN3A TGGCTGGGATGGCTTGTTAG TTGGAAGGATTGGCTGCCAT
SHOX CGGAAGGGATCTACGAGTGC GCTGGAGTTCTTGCTGTTGC
SULT4A1 GGCTTGCTACAGGAAGTGGT CCACCATGGATTCCAGCTGT
TOX2 AACCTCCCTGACCCTTCACT CCGAAGGTAGCATTGGGGTT
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EdgeR (ii). Data are available as compiled .xlsx spreadsheets (A) or
individual .csv files (B). (ZIP 24942 kb)
Additional file 7: Figure S4. A) Number of genes identified as
differentially expressed (q < 0.05) in each ganglion and in the grouped
Top/Tmm/VA ganglia by DESeq and EdgeR. B) Significant Gene Ontology
enrichment (q < 0.05) for differentially expressed genes reported by both
DESeq and EdgeR in each ganglion. Redundant GO terms were removed
using REVIGO. The Hinton plot displays the FDR (Benjamini and Hochberg)
corrected q-value. Top: trigeminal ophthalmic; Tmm: trigeminal maxilloman-
dibular, VA: vestibulo-acoustic, P: petrosal, N: nodose. (PDF 385 kb)
Additional file 8: Average normalized read count in ganglion of
focus relative to all other ganglia, fold change and q-value (Benjamini
and Hochberg) for the 134 high confidence markers computed using
DESeq. (XLSX 22 kb)
Additional file 9: Figure S5. Molecular phylogenetic analysis and
expression levels of POU4/BRN3 family genes. A) Maximum likelihood
tree of POU4/BRN3 gene family in vertebrates. 4 paralogy groups are
found across vertebrates. POU4F1.2, named after the Xenopus homologue,
is present in chicken but was not found in mammals. Accession numbers
are shown next to each entry and bootstrap values are shown at each
node. The unique Pou4 sequence from invertebrate deuterostomes are
used as an outgroup and the tree is rooted with Lottia giantea Pou4.
Species abbreviations: Brafl: Branchiostoma floridae; Calmi: Callorhynchus
milii; Chrpi: Chrysemys picta; Danre: Danio rerio; Galga: Gallus gallus; Homsa:
Homo sapiens; Lotgi: Lottia gigantea; Sacko: Saccoglossus kowalevskii; Strpu:
Strongylocentrotus purpuratus; Xentr: Xenopus tropicalis. B) Expression levels
(RPKM) for chicken POU4F1 and POU4F1.2 across five cranial sensory ganglia
assessed by RNAseq. The two genes are collectively expressed at high levels
in the somatic but not visceral sensory neurons. Top: trigeminal ophthalmic;
Tmm: trigeminal maxillomandibular, VA: vestibulo-acoustic, P: petrosal,
N: nodose. (PDF 8575 kb)
Additional file 10: Gene Ontology annotations for the 134 high
confidence ganglion-specific markers. (XLSX 13 kb)
Additional file 11: Figure S6. Expression patterns of putative ganglia-
specific markers that didn’t match expectations. In situ hybridization in
wholemount and on sections at the level of the trigeminal maxillomandibular
(Tmm), vestibulo-acoustic (VA) and petrosal (P) ganglia. A) LHX4 expression
was detected at relatively high levels in the ventral hindbrain but only at very
low levels in the petrosal ganglion. B) OTX2 staining can be observed at high
levels in the rhombic lip but only slightly higher in the trigeminal than in the
vestibulo-acoustic and petrosal ganglia. C) TOX2 staining was only detected
at very low levels in the ganglia in sections. D-F) MECOM, PRRX1 and PRRX2
expression was observed at high levels in the mesenchyme around, but not
within, the cranial sensory ganglia. (TIF 8124 kb)
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